We are live on ! Find out more
EIP

Epoch Investment Partners Portfolio holdings

AUM $16.5B
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
+20.38%
1 Year Est. Return
+24.3%
3 Year Est. Return
+77.95%
5 Year Est. Return
+103.29%
10 Year Est. Return
+404.8%
AUM
$19.4B
AUM Growth
+$2.88B
Cap. Flow
-$106M
Cap. Flow %
-0.55%
Top 10 Hldgs %
21.04%
Holding
305
New
36
Increased
87
Reduced
158
Closed
20

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$193M
2
NOC icon
Northrop Grumman
NOC
+$145M
3
TMUS icon
T-Mobile US
TMUS
+$127M
4
MRK icon
Merck
MRK
+$110M
5
AAPL icon
Apple
AAPL
+$95.2M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$191M
2
CNP icon
CenterPoint Energy
CNP
+$115M
3
CNC icon
Centene
CNC
+$103M
4
KO icon
Coca-Cola
KO
+$92.4M
5
BA icon
Boeing
BA
+$89.9M

Sector Composition

Rank Sector Weight
1 Technology 19.96%
2 Healthcare 17.37%
3 Financials 10.98%
4 Communication Services 10.95%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAP icon
301
Molson Coors Class B
TAP
$7.93B
-224,048
Closed -$8.74M
TYL icon
302
Tyler Technologies
TYL
$13B
-56,547
Closed -$16.8M
WFC icon
303
Wells Fargo
WFC
$265B
-1,826,732
Closed -$52.4M
DISCK
304
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-266,972
Closed -$4.68M
RTN
305
DELISTED
Raytheon Company
RTN
-279,834
Closed -$36.7M

Similar funds

Epoch Investment Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Epoch Investment Partners held 305 positions worth $19.4B, up 17% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Epoch Investment Partners's Q2 2020 filing shows 36 new, 87 increased, 158 reduced and 20 closed positions. Its largest new stake was Thermo Fisher Scientific: 574,518 shares worth $208M. The largest sale was Pfizer, an estimated $191M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Epoch Investment Partners's largest Q2 2020 buy was Thermo Fisher Scientific: 574,518 shares worth $208M.
  • Epoch Investment Partners added most to Merck in Q2 2020, an estimated $110M increase.
  • Epoch Investment Partners's biggest Q2 2020 reduction was Pfizer, cutting an estimated $191M.
  • Epoch Investment Partners fully exited CenterPoint Energy in Q2 2020, selling an estimated $115M.
  • Epoch Investment Partners's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2020.
  • Epoch Investment Partners opened 36 new positions and closed 20 in Q2 2020.
  • Epoch Investment Partners's portfolio value rose 17% quarter-over-quarter to $19.4B.

Based on Epoch Investment Partners's 13F filing for Q2 2020, filed 13 Aug 2020.